Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that the first ...

Rationalist fundamentalism is not merely a philosophical stance but a political weapon—used to enforce ideological conformity ...

The mysteries of gargalesis have tickled the minds of people for centuries. Thinkers from the Greek philosophers Socrates and ...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Investigating this difference further could reveal clues to brain development in people with autism, the scientists say, but ...

These two TSX stocks may not be in the spotlight yet, but they’re built for long-term growth and still offer real value today ...

A growing number of climate activists are taking up a fresh idea as a rallying cry and a legal strategy: Nature, in all its ...

Learn more about whether The Descartes Systems Group Inc. or Samsara Inc. is a better investment based on AAII's A+ Investor ...

Zurich North America announces leaders in national accounts and underwriting; Aon's new chief strategy officer, plus more ...